Evidence map›Paper›PMID 42352355›Full record

ArticleBiomolecules2026

Sustainable Production of High-Performance Antimicrobial Scaffold via an Engineered

Ehab Marwan-Abdelbaset, Xiaoyun Lu, Dan Tan

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ehab Marwan-AbdelbasetKey Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
Xiaoyun LuKey Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.ORCID 0000-0003-3284-4729
Dan TanKey Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.

Funding

Xi'an Jiaotong University 2020ZFY004571
6 · The paper itself

Abstract

This study presents a transformative "one-pot" biorefinery approach for the simultaneous production of hyaluronic acid (HA) and polyhydroxybutyrate (PHB) using an engineered, non-pathogenic

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsHalomonasHyaluronic AcidHydroxybutyratesMetabolic EngineeringFermentationNanoparticlesPolyestersPolyhydroxybutyratesAnti-Bacterial AgentsAnti-Infective AgentsHyaluronic AcidHydroxybutyratesPolyesterspolyhydroxybutyratePolyhydroxybutyratesantimicrobial scaffoldco-productionHalomonas bluephagenesis TD01 as (NGIB)hyaluronic acidmetabolic engineeringone-step fermentationPHB-nanoparticles

Identifiers

PMID42352355
PMCPMC13297420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.